Federal Register / Vol. 73, No.
38 / Tuesday, February 26, 2008 / Notices 10249
Personal Protective Technology
Laboratory, National Institute for
Occupational Safety and Health, CDC,
626 Cochrans Mill Road, Pittsburgh, PA
15236, Telephone (412) 386–6465.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: February 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–3569 Filed 2–25–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Development
and Testing of an HIV Prevention
Intervention Targeting Black
Bisexually Active Men, Funding
Opportunity Announcement (FOA)
Number PS 08–002
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 10 a.m.–2 p.m.,
April 9, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Development and Testing of
an HIV Prevention Intervention Targeting
Black Bisexually Active Men, FOA Number
PS 08–002.’’
Contact Person for More Information:
Susan B. Stanton, D.D.S., Scientific Review
Administrator, CDC, 1600 Clifton Road, NE.,
MS D72, Atlanta, GA 30333, Telephone (404)
639–4640.
The Director, Management Analysis and
mstockstill on PROD1PC66 with NOTICES
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
VerDate Aug<31>2005 19:29 Feb 25, 2008 Jkt 214001
Dated: February 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–3577 Filed 2–25–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Centers for
Agriculture Disease and Injury
Research, Program Announcement
(PA) PAR 006–057
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date:
9 a.m.–5 p.m., March 27, 2008 (Closed).
9 a.m.–5 p.m., March 28, 2008 (Closed).
Place: Marriott Waterfront, 80
Compromise Street, Annapolis, MD
21401.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the review, discussion, and
evaluation of ‘‘Centers for Agriculture
Disease and Injury Research, PA PAR
006–057.’’
Contact Person for More Information:
Stephen Olenchock, PhD, Scientific
Review Administrator, Office of
Extramural Coordination and Special
Projects, National Institute for
Occupational Safety and Health, CDC,
1095 Willowdale Road, Morgantown,
WV 26505, Telephone (304) 285–6271.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: February 19, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–3589 Filed 2–25–08; 8:45 am]
BILLING CODE 4163–18–P
PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\26FEN1.SGM
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Privacy Act of 1974; Report of a
Modified or Altered System of Records
AGENCY: Department of Health and
Human Services (HHS), Center for
Medicare & Medicaid Services (CMS).
ACTION: Notice of a Modified or Altered
System of Records (SOR).
SUMMARY: In accordance with the
requirements of the Privacy Act of 1974,
we are proposing to modify or alter
existing system of records titled,
‘‘Enrollment Data Base (EDB), System
No. 09–70–0502, last modified 67
Federal Register 3203 (January 23,
2002). The EDB currently maintains
enrollment-related data, data elements
pertaining to Medicare Secondary Payer
(MSP), and data regarding Direct billing
and Third Part premium collection
information for Medicare premiums. We
are amending the purpose of the EDB to
include maintaining enrollment and
entitlement data currently maintained
in the following CMS systems of
records: Medicare Beneficiary Database
(MBD), System No. 09–70–0536; and the
Medicare Prescription Drug System
(MARx), System No. 09–70–4001.
We are modifying the language in
published routine use number 1 to
permit disclosures to a grantee of a
CMS-administered grant program that
perform a task for the agency. CMS
occasionally contracts out certain of its
functions when doing so would
contribute to effective and efficient
operations. CMS must be able to give a
contractor, consultant or grantee
whatever information is necessary for
the contractor, consultant, or grantee to
fulfill its duties. We will modify
existing routine use number 5 that
permits disclosure to Peer Review
Organizations (PRO). Organizations
previously referred to as PROs will be
renamed to read: Quality Improvement
Organizations (QIO). Information will be
disclosed to QIOs for health care quality
improvement projects. The modified
routine use will be renumbered as
routine use number 5. We will delete
published routine use number 8
authorizing disclosure to support
constituent requests made to a
congressional representative. If an
authorization for the disclosure has
been obtained from the data subject,
then no routine use is needed. The
Privacy Act allows for disclosures with
the ‘‘prior written consent’’ of the data
subject.
26FEN1